Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An Open-Label, Sequential, Dose Escalation Study of the Pharmacokinetics, Safety, and Preliminary Efficacy of MDT-15 in Subjects With Lumbosacral Radiculopathy

Next Previous
Search
Trial Profile

An Open-Label, Sequential, Dose Escalation Study of the Pharmacokinetics, Safety, and Preliminary Efficacy of MDT-15 in Subjects With Lumbosacral Radiculopathy

Status: Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 17 Sep 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs MDT 15 (Primary)
  • Indications Radiculopathy; Sciatica
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Medtronic

Most Recent Events

  • 11 Sep 2015 Planned End Date changed from 1 Aug 2016 to 1 Sep 2016 as reported by clinicalTrials.gov.
  • 11 Sep 2015 Status changed from recruiting to active, no longer recruiting as reported by clinicalTrials.gov.
  • 10 Aug 2015 Planned End Date changed from 1 Jan 2016 to 1 Aug 2016 as reported by clinicalTrials.gov record.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top